股东委托书协议
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-016003 Act: 34 Size: 1 MB 网页链接
简介:Aytu BioPharma, Inc.最初于2002年8月9日在美国科罗拉多州成立。该公司是一家专注于将新型疗法和消费者医疗保健产品商业化的制药公司。该公司通过两个业务部门运营:(一)Rx部门,包括处方药产品;(二)消费者保健部门,包括各种消费者医疗保健产品。
今开:2.81 | 昨收:2.82 |
最高:2.84 | 最低:2.78 |
涨停价: | 跌停价: |
总市值:16961409 |
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-016003 Act: 34 Size: 1 MB 网页链接
Aytu BioPharma(AYTU)06-18 20:15
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 2.03, 7.01, 8.01, and 9.01 Accession Number: 0001437749-24-020590 Act: 34 Size: 1 MB 网页链接
Aytu BioPharma(AYTU)07-03 05:25
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-24-000527 Size: 6 KB 网页链接
Aytu BioPharma(AYTU)05-16 04:25
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-017051 Act: 34 Size: 8 MB 网页链接
Aytu BioPharma(AYTU)05-16 04:25
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-017058 Act: 34 Size: 482 KB 网页链接
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-24-016004 Act: 34 Size: 544 KB 网页链接
Aytu BioPharma(AYTU)06-19 17:27
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-072841 Act: 34 Size: 63 KB 网页链接
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ ARS Annual Report to Security Holders Accession Number: 0001437749-24-016006 Act: 34 Size: 1 MB 网页链接
Aytu BioPharma(AYTU)06-19 17:26
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-072893 Size: 12 KB 网页链接
逍遥投资派2023-05-13 19:25
$Aytu BioPharma(AYTU)$ 5年来营收持续增长,营业利润和净利润亏损持续扩大,2023前两季度营收继续增长,营业利润和净利润亏损大幅缩窄,可以再观察几个季度再做判断。查看全文
鲜克有终72021-06-08 18:06
$Aytu BioPharma(AYTU)$ 差不多 上车试试查看全文
鲜克有终72021-06-08 16:37
$Aytu BioPharma(AYTU)$ 跌到6.8合理查看全文
鲜克有终72021-06-08 16:31
$Aytu BioPharma(AYTU)$ 六块爱理不理 8块高攀不起查看全文
XP稳中求进2021-05-10 21:56
$Aytu BioPharma(AYTU)$ 你怎么还不倒闭啊?查看全文
闲适游走2021-04-06 00:28
$Aytu BioPharma(AYTU)$ 一合并倒喋喋不休了……查看全文
时尚风云2021-03-22 22:57
$Aytu BioScience(AYTU)$ 故意洗一洗的,拿住就是十倍查看全文
XYZ-DeepInsight2021-03-22 17:31
$Aytu BioScience(AYTU)$ 今日看高13查看全文
天语77882021-03-16 21:40
天语77882021-03-10 20:50
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-24-000527 Size: 6 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-072841 Act: 34 Size: 63 KB 网页链接
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-072893 Size: 12 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 2.03, 7.01, 8.01, and 9.01 Accession Number: 0001437749-24-020590 Act: 34 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-017051 Act: 34 Size: 8 MB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-017058 Act: 34 Size: 482 KB 网页链接
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-016003 Act: 34 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-24-016004 Act: 34 Size: 544 KB 网页链接
$Aytu BioPharma(AYTU)$ ARS Annual Report to Security Holders Accession Number: 0001437749-24-016006 Act: 34 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-24-000340 Size: 7 KB 网页链接